Keratoacanthomas associated with sorafenib therapy

J Am Acad Dermatol. 2007 Jan;56(1):171-2. doi: 10.1016/j.jaad.2006.10.032.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Arm
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use
  • Facial Dermatoses / chemically induced
  • Female
  • Humans
  • Keratoacanthoma / chemically induced*
  • Keratoacanthoma / surgery
  • Leiomyosarcoma / drug therapy
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Neck
  • Neoplasm Metastasis
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Prostatic Neoplasms / drug therapy
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Skin Diseases / chemically induced*
  • Skin Diseases / surgery
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • Niacinamide
  • Sorafenib